GNE-8505
GNE-8505 is an orally available inhibitor of Dual leucine zipper kinase (DLK) [1].
Product Specifications
CAS Number
[1620573-48-9]
UNSPSC
12352005
Target
MAP3K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gne-8505.html
Concentration
10mM
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(F)C1=CC(C2=NN(C([C@@H]3[C@]4([H])[C@@]3([H])CN(C5COC5)C4)=C2)CC6CC6)=CN=C1N
Molecular Formula
C21H24F3N5O
Molecular Weight
419.44
References & Citations
[1]Le Pichon CE, et al. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med. 2017 Aug 16;9 (403) . pii: eaag0394.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1079076-01 1 mg (E-Coli)
Recombinant Burkholderia pseudomallei Protoheme IX farnesyltransferase (ctaB), partial
Ask
View Details MBS1079076-02 1 mg (Yeast)
Recombinant Burkholderia pseudomallei Protoheme IX farnesyltransferase (ctaB), partial
Ask
View Details 
MBS6369287-01 0.1 mL
AKR1B1 (Aldose Reductase, AR, Aldehyde Reductase, Aldo-keto Reductase Family 1 Member B1, ALDR1) APC
Ask
View Details